Concepedia

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer

Che-Pei Kung, Kyle A. Cottrell, Sua Ryu, Emily R. Bramel, Raleigh D. Kladney, Emily A. Bao, Eric C. Freeman, Thwisha Sabloak, Leonard B. Maggi, Jason D. Weber

Oncogene · 2020 · 106 citations · 51 references

DOIFull text

Open access

Concepts

References

51

<tt>edgeR</tt> : a Bioconductor package for differential expression analysis of digital gene expression data

Mark D. Robinson, Davis J. McCarthy, Gordon K. Smyth · Bioinformatics · 2009 · 44.5K citations · Full text

, , +14

Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells

Robin M. Meyers, Jordan Bryan, James M. McFarland et al. · Nature Genetics · 2017 · 2.2K citations · Full text

, , +15

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Brian D. Lehmann, Bojana Jovanović, Xi Chen et al. · PLoS ONE · 2016 · 1.4K citations · Full text

, , +17

RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself

Brian Liddicoat, Robert Piskol, Alistair M. Chalk et al. · Science · 2015 · 999 citations · Full text

, , +15

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

Jeffrey J. Ishizuka, Robert T. Manguso, Collins Cheruiyot et al. · Nature · 2018 · 715 citations · Full text

, , +14